October 01, 2024
2 min watch
Save
VIDEO: Optogenetic therapy shows promise for inherited retinal dystrophies
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Paulo-Eduardo Stanga, MD, explains the principles and mechanisms of action of optogenetic gene therapy.
Nanoscope Therapeutics has developed therapies that use multi-characteristic opsin to resensitize the retina, showing promise for inherited retinal dystrophies (IRDs) and geographic atrophy.
“This is not science fiction — this is a reality. We expect this therapy to become commercially available for IRDs sometime next year,” Stanga said.
Published by:
Sources/Disclosures
Collapse
Source:
Stanga P. Optogenetic therapies for IRDs. Presented at: Euretina congress; Sept. 19-22, 2024; Barcelona, Spain.
Disclosures:
Stanga reports consulting for Nanoscope Therapeutics.
Read more about